Venture Map · Round

Gate2Brain — Other · €7M

Announced 2026-06-16 · Barcelona · Healthtech & Bio

Blood-brain-barrier drug-delivery biotech (UB/IRB spin-off) secured €7M from strategic partner Shilpa Biocare (30.4% stake) — its largest raise to date — to advance G2B-002 for pediatric brain tumors.

RoundOther Amount€7M LeadShilpa Biocare Date2026-06-16 CityBarcelona SectorHealthtech & Bio

Source article ↗ · gate2brain.com ↗

The company

Investors 1

Shilpa Biocare
InvestorLeadIndia

← All funding rounds

Start typing to search across everything.
↑↓ navigate↵ openesc close